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Abstract
Background: Llamas (Lama glama) are induced ovulators and the process of ovulation depends on dominant
follicular size. In addition, a close relationship between behavioural estrus and ovulation is not registered in llamas.
Therefore, the exogenous control of follicular development with hormones aims to predict the optimal time to
mate. Oestradiol-17b (E2) and its esters are currently used in domestic species, including camelids, in
synchronization treatments. But, in llamas, there is no reports regarding the appropriate dosages to be used and
most protocols have been designed by extrapolation from those recommended for other ruminants. The aim of
the present study was to characterize plasma E2 concentrations in intact female llamas following a single
intramuscular (i.m.) injection of two oestradiol esters: oestradiol benzoate (EB) and oestradiol cypionate (ECP).
Methods: Twelve non pregnant and non lactating sexually mature llamas were i.m. injected on day 0 with 2.5 mg
of EB (EB group, n = 6) or ECP (ECP group, n = 6). Blood samples were collected immediately before injection, at 1,
6, 12, 24 h after treatment and then daily until day 14 post injection. Changes in hormone concentrations with
time were analyzed in each group by analysis of variance (ANOVA) using a repeated measures (within-SS) design.
Plasma E2 concentrations and area under the concentration-time curve (AUC) values were compared between
groups by ANOVA. In all cases a Least-Significant Difference test (LSD) was used to determine differences between
means. Hormonal and AUC data are expressed as mean ± S.E.M.
Results: Peak plasma E2 concentrations were achieved earlier and were higher in EB group than in ECP group.
Thereafter, E2 returned to physiological concentrations earlier in EB group (day 5) than in ECP group (day 9).
Although plasma E2 profiles differed over time among groups there were no differences between them on AUC
values.
Conclusions: The i.m. injection of a single dose of both oestradiol esters resulted in plasma E2 concentrations
exceeding physiological values for a variable period. Moreover, the plasma E2 profiles observed depended on the
derivative of oestradiol administered. This basic information becomes relevant at defining treatment protocols
including oestrogens in llamas.
Background
Llamas (Lama glama) are ruminants with physiological
peculiarities, particularly regarding their reproductive
physiology. Ovarian follicles develop in a wave-like pat-
tern as in other ruminants: cows [1]; ewes [2]; goats [3],
but the process of ovulation requires the stimulus of
mating and ejaculation [4-8]. Moreover, only growing,
dominant follicles ≥ 7 mm in diameter present at the
time of mating have the ability to ovulate [9]. In the
absence of ovulation, successive waves of follicular
growth and regression that generally overlap, proceed
[10,11]. The oestrogens produced during those waves
determine long periods of receptivity (≥ 30 days), inter-
rupted by short stages of male rejection [4,12]. Thus, a
set of signals indicative of the presence of a mature folli-
cle is not registered in the llama [5,6,11]. Furthermore,
the female might accept the male in the absence of a
qualified follicle resulting in ovulation failure. Therefore,
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the control of follicular development with exogenous
hormones assuring the presence of a healthy mature fol-
licle at a fixed time after treatment would enable the
implementation of reproductive technologies leading to
an increase in productivity.
Oestrogens are a family of steroid hormones involved
in female reproductive processes regulating and sustain-
ing sexual development and reproductive function. Oes-
tradiol-17b (E2) is the most abundant and active of the
endogenous oestrogens produced by the ovary [13]. In
addition, oestradiol esters are a group of synthetic oestro-
gens that includes: oestradiol benzoate (EB), oestradiol
valerate (EV) and oestradiol cypionate (ECP). Oestradiol-
17b and EB are commonly used to induce follicular
regression and to synchronize wave emergence and ovu-
lation in progestin-treated cattle [14-17]. The inclusion
of ECP in hormonal regimens has increased in recent
years as in some countries is the only ester available and
licensed for use in cattle, but its success to hasten wave
emergence has been relatively variable to date [18,19].
The time to wave emergence after E2treatment in cattle,
appears to depend on the dose and formulation adminis-
tered. It appears that the greater the circulating concen-
trations of E2, or the time to return to physiological
range, the greater are follicular and FSH suppression
[16,20-22]. Thus the use of an “optimal” dose or formula-
tion of E2 in hormonal regimens is emphasized by the
previous observations. Conversely, in camelids informa-
tion regarding the effects of oestrogens on follicular
activity is scanty and controversial [23-26]. In addition,
there is no reports regarding the appropriate dosages to
be used in llamas and most protocols have been designed
by extrapolation from those recommended for other
ruminants. While establishing those dose regimens, it has
never been considered that camelids show pharmacologi-
cal differences for the metabolism of several drugs as
compared to other ruminants [27-30].
The study hereby reported, was designed to provide a
comparative characterization of plasma E2 concentra-
tions following a single i.m. injection of two oestradiol
esters (EB and ECP). This information would provide
basic knowledge useful for a more rational use of these
drugs in the species.
Methods
Animals and treatments
The experimental design and animal care were per-
formed in compliance with regulations set by the Ani-
mal Welfare Committee at the Faculty of Veterinary
Sciences, UNCPBA, Tandil, Argentina (37°S, 60°W)
where activities were carried out. Animals were kept iso-
lated from males and fed pasture hay and had free
access to water during the entire experimental period.
Twelve sexually mature, non pregnant and non lactating
female llamas (107.5 ± 17.68 Kg) were randomly divided
into two treatment groups: EB (n = 6) and ECP (n = 6).
On day 0 all animals received a single i.m. injection (0
h) of 2.5 mg of oestradiol benzoate (EB, Benzoato de
Estradiol Syntex®, Syntex SA, Buenos Aires, Argentina)
or oestradiol cypionate (ECP, ecp estradiol®, König, Bue-
nos Aires, Argentina) into the hind leg in the region of
the semitendinosus muscle. The dose of EB was selected
based on previous studies in llamas and alpacas [24,31].
In general, a larger dose of EB has been used in came-
lids as compared to that used in synchronization pro-
grams in cattle [15,24,26,31], probably in relation to a
higher metabolic rate reported in camelids for different
drugs [27-30]. In addition, to allow a direct comparison
between esters and due to the lack of reports using ECP
in the specie the same dose was used for ECP.
Blood sampling
Blood samples were collected into heparinized tubes
immediately before injection, at 1, 6, 12, 24 h after treat-
ment, and then daily until day 14 post injection. In
order to minimize damage to the jugular veins due to
the high frequency sampling protocol, venipuncture was
performed alternately at high, medium and low posi-
tions on the left and right sides of the neck as pre-
viously described by Aba et al. [32]. Plasma samples
were separated by centrifugation and stored at -20°C
until analyzed.
Hormone determinations
Oestradiol-17b plasma concentrations were measured
using an RIA Kit (Siemens Medical Solutions Diagnos-
tics, Los Angeles, CA, USA) reported for use with
bovine plasma [33], and validated for use with llama
plasma after minor modifications [6]. Plasma and stan-
dards were previously extracted using diethyl ether
(Merck, Buenos Aires, Argentina). The intra-assay coef-
ficient of variation was below 10% for concentrations
between 5.6 and 180 pmol l-1. The inter-assay coefficient
of variation, calculated from the precision profiles of five
standard curves, was below 6% for concentrations
between 5.6 and 180 pmol l-1. The lowest amount of E2
detectable was 5.6 pmol l-1. Plasma progesterone (P4)
concentrations were measured using an RIA Kit (Sie-
mens Medical Solutions Diagnostics, Los Angeles, CA,
USA) previously validated for use with llama plasma
[34]. The sensitivity of the assay was 0.3 nmol l-1 and
the intra-assay coefficient of variation was below 13%
for concentrations between 0.4 and 128 nmol l-1. All
samples were measured in duplicates. Hormone concen-
trations are expressed in SI units. To convert from pmol
l-1 to pg ml-1 and from nmol l-1 to ng ml-1, a factor of
3.7 for oestradiol-17b and 3.2 for progesterone should
be used.
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Analysis of data
In order to establish a physiological plasma E2 concen-
tration upper limit before treatment, twice the standard
deviation (SD) was added to the general mean as pre-
viously described by Vynckier et al. [35]. Any concentra-
tion above (P < 0.05) this limit was considered
pharmacological. Changes in hormone concentrations
with time on each treatment group were analyzed by
analysis of variance (ANOVA) using a repeated mea-
sures (within-SS) design. Mean E2 concentrations at
each time were statistically compared among groups by
ANOVA. In all cases, a Fisher’s Least-Significant Differ-
ence test (LSD) was used to determine differences
between means. Log-transformation was used for plasma
E2 concentrations before analyses to stabilize variances.
The area under the concentration-time curve (AUC)
from time zero to the last measurable concentration was
calculated by the trapezoidal rule [36]. The AUC values
obtained after the injection of both esters was statisti-
cally compared between groups by ANOVA. Statistical
analyses were carried out using the Statistica/W, release
4.0 software package (Statsoft Inc., Tulsa, OK, USA,
1993). Statistical significance was set at P < 0.05. Hor-
monal and AUC data are expressed as mean ± S.E.M
unless otherwise specified.
Results
Physiological plasma E2 concentrations
Oestradiol-17b plasma concentrations varied widely
between animals at the beginning of the study (ranging
from 13.7 to 44.7 pmol l-1). Mean plasma E2 concentra-
tion before injection (considering all females) was 33.1 ±
11.7 pmol l-1 (mean ± SD). The physiological upper
limit for plasma E2 concentrations was established at
56.5 pmol l1.
Plasma E2 concentrations and AUC values after oestradiol
esters injection
The administration of both formulations resulted in
plasma E2concentrations largely exceeding physiological
values. Mean plasma E2concentrations during 14 days
after i.m. injection of EB and ECP are shown in Figure
1. In EB group, E2 plasma concentrations increased
sharply (P < 0.0001) by 1 h after injection, reaching
peak concentrations (484.9 ± 85.6 pmol l-1) by 6 h after
injection. Oestradiol-17b plasma concentrations
remained elevated until 12 h and then followed a bipha-
sic decline. Firstly, E2 concentrations underwent a sharp
decrease between 12 h and day 1, remained relatively
stable between days 1 and 2 and steadily decreased
onwards returning to physiological values by day 5 post
injection. In ECP group, E2 concentrations increased
slowly from 6 h after injection (P < 0.0001) until peak
concentrations (157.1 ± 8.7 pmol l-1) were reached on
day 1. Thereafter, plasma E2 concentrations declined
slowly, until concentrations no longer distinguishable
from physiological were attained on day 9. Subsequently,
plasma E2 concentrations fluctuated close to physiologi-
cal values until the end of the study.
Although plasma E2 concentrations profiles differ
according to treatment, the AUC values obtained follow-
ing injection were similar between groups (EB: 1336.01
± 157.4 pmol*day/l; ECP: 1189.78 ± 87.44 pmol*day/l; P
= 0.5306). Thus, mean E2 concentrations in EB group
were higher than in ECP group at all times beyond the
0 h sample until day 2 with a rapid fell onwards. In con-
trast, in ECP group mean E2 concentrations experienced
a slower increase, but more prolonged in time, attaining
values higher than in EB group between day 6 and day
13 inclusive. On days 3 to 5 and on day 14 plasma E2
concentrations were similar among groups. Plasma P4
concentrations remained bellow 3 nmol l-1 in all females
during the entire period of study.
Discussion
Plasma E2 concentrations and its variability between ani-
mals recorded before treatment in the present study
(range from 13.7 to 44.7 pmol l-1) are consistent with
previous reports in llamas [6,37,38]. This observation
indicates animals were at different stages of follicular
development at the time of treatment, as it has been
established a close relationship between follicular activ-
ity and E2 secretion in llamas [5,6,38,39]. In addition,
the plasma E2 concentration established as the physiolo-
gical upper limit in the present study was somehow in
agreement to that previously registered during the folli-
cular phase (17 to 47 pmol l-1) in llamas [38]. The fact
that plasma P4 concentrations remained bellow 3 nmol
l-1 in all cases indicates that no ovulations occurred dur-
ing the study [6].
To our knowledge, this is the first report showing the
plasma E2 profile following a single i.m. injection of
ECP and its comparison to the profile obtained after
injection of EB in llamas. Treatment with both oestra-
diol derivatives induced plasma E2 concentrations
exceeding those considered physiological for the species.
Moreover, the plasma E2profiles recorded in the present
study clearly depended on the ester administered and
were consistent with that registered in cows by Vynckier
et al. [35]. Plasma E2 concentrations increased rapidly
and peaked earlier in EB group with values three-times
higher than in ECP group. Similar results were pre-
viously observed after EB injection in bovines [21,22].
Peak plasma E2 concentrations achieved after EB
injection in the present study were higher than those
recorded before in camelids [24,31] and were attained
earlier than observed by others [24] in alpacas. Although
there is no clear explanation for the divergences
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registered between studies, it could be speculated that
differences in blood sampling schedule, sensitivity of
hormone assays and formulation of hormonal products,
may be responsible for the discrepancy.
Once peak plasma E2 concentrations were reached,
the declination rate also differed between esters. The
biphasic decline of plasma E2concentrations until phy-
siological values on day 5 in EB group is in agreement
with previous reports in alpacas and cows [24,35]. As
stated by Vynckier et al. [35] these biphasic decline sug-
gest an initial phase of distribution followed by an elimi-
nation phase. In contrast, in ECP group, the decreasing
phase of the curve was shorter and plasma E2 concen-
trations fluctuated close to physiological values from day
9 onwards. Although the pattern of decline observed for
ECP in our study is consistent with that recorded in
cows by Vynckier et al. [35], they showed that concen-
trations returned to physiological values slightly earlier
(day 7) in this species. The slower return to physiologi-
cal values in ECP compared to EB group indicates a
longer half-life for ECP as has been registered previously
in cattle [17,19,35].
From the analysis of plasma E2 concentrations, it is
apparent that ECP was absorbed at a lower rate than
EB, but persisted elevated in plasma for a longer period
(8 and 4 days, respectively). Besides the different rates of
absorption, the same amount of drug was released from
the injection site for both esters, since by the end of the
study the AUCs values were similar between groups.
These findings are consistent with the fact that the
esterification process prolongs the half-life of E2. Appar-
ently, the ester injected influences the mode that E2 is
released from the injection site. Thus, there is an inverse
relationship between the extension of the ester chain
and its water solubility and consequently, on its absorp-
tion rate. Once in circulation, the esters are hydrolyzed
to E2, the active hormone. Consequently, the duration
of action appears to depend on the rate of absorption
more than the metabolism [40].
It has been suggested in llamas that hormonal treat-
ments with progestogens are effective in completely pre-
vent follicular development for a period of up to 7 days
with the lowest follicular activity registered between
days 5 and 7 after beginning of treatment [32-38].
Thereafter, most attempts to control follicular activity
includes short protocols (5 to 7 days) and a combination
of a progestogen and oestrogens. According to the
results hereby presented, E2 plasma concentrations
would remain at pharmacological concentrations beyond
the day of progestogen withdrawal after ECP treatment.
Conversely, plasma E2 concentrations would have return
to physiological values before the end of the synchroni-
zation protocol after EB injection. Whether this might
influence the outcome of the synchronization treatment
or not remains to be elucidated.
Conclusions
To our knowledge, this is the first study that provides a
characterization of the plasma E2 concentrations profile
following a single i.m. injection of ECP and a direct
comparison to that obtained after EB injection in intact
female llamas. Both esters effectively induced pharmaco-
logical E2 concentrations, however, plasma E2 profiles
depended on the formulation administered. Peak plasma
E2 concentrations were higher and were attained earlier
after EB injection compared to ECP with an earlier
return to physiological values. This basic information
becomes relevant at defining treatment protocols includ-
ing oestrogens in llamas.
Acknowledgements
This study was supported by grants from Agencia Nacional de Promoción
Científica y Tecnológica (PICT 08-14231). MVC and CPB are holders of a
fellowship from Consejo Nacional de Investigaciones Científicas y Técnicas
(CONICET).
Authors’ contributions
MVC participated in developing the design of the experiment, carried out
the experiment, gathered and analyzed the data, and drafted the
manuscript. CPB contributed in carrying out the experiment and with
contents of the manuscript. MAA as the director of the doctoral project of
MVC designed the experiment, contributed in carrying out the experiment,
Figure 1 Mean plasma oestradiol 17-b concentration in llamas
injected intramuscularly with oestradiol benzoate or oestradiol
cypionate. Mean plasma oestradiol 17-b (E2) concentration
immediately before injection (0 h), at 1, 6, 12, 24 h post injection,
and then daily until day 14 after a single intramuscular injection of
2.5 mg of oestradiol benzoate (EB group; closed circle) or oestradiol
cypionate (ECP group; open circle) in llamas (n = 6/group). The
broken line indicates the physiological plasma E2 concentrations
upper limit established. (*)Mean values differ between groups at P <
0.05. Within treatments groups, a solid (EB group) or dashed (ECP
group) arrow indicates the day on which plasma E2 concentrations
returned to physiological values (P > 0.05).
Cavilla et al. Acta Veterinaria Scandinavica 2010, 52:13
http://www.actavetscand.com/content/52/1/13
Page 4 of 5
with the analysis of the data and revising critically the contents of the
manuscript. All authors have read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 15 December 2009
Accepted: 11 February 2010 Published: 11 February 2010
References
1. Ginther OJ, Kastelic JP, Knoft L: Composition and characteristics of
follicular waves during the bovine estrus cycle. Anim Reprod Sci 1989,
20:187-200.
2. Evans AC, Duffy P, Hynes N, Boland MP: Waves of follicle development
during the estrous cycle in sheep. Theriogenology 2000, 53:699-715.
3. Rubianes E, Menchaca A: The pattern and manipulation of ovarian
follicular growth in goats. Anim Reprod Sci 2000, 78:271-287, (review).
4. San-Martín M, Copaira M, Zuniga J, Rodreguez R, Bustinza G, Acosta L:
Aspects of reproduction in the alpaca. J Reprod Fertil 1968, 16:395-399.
5. Bravo PW, Fowler ME, Stabenfeldt GH, Lasley BL: Ovarian follicular
dynamics in the llama. Biol Reprod 1990, 43:579-585.
6. Aba MA, Forsberg M, Kindahl H, Sumar J, Edqvist LE: Endocrine changes
after mating in pregnant and non-pregnant llamas and alpacas. Acta Vet
Scand 1995, 36:489-498.
7. Chen BX, Yuen ZX, Pan GW: Semen-induced ovulation in the Bactrian
camel (Camelus bactrianus). J Reprod Fertil 1985, 74:335-339.
8. Adams GP, Ratto MH, Huanca W, Singh J: Ovulation-Inducing Factor in the
Seminal Plasma of Alpacas and Llamas. Biol Reprod 2005, 73:452-457.
9. Bravo PW, Stabenfeldt GH, Lasley BL, Fowler ME: The effect of ovarian
follicle size on pituitary and ovarian responses to copulation in
domesticated South American camelids. Biol Reprod 1991, 45:553-559.
10. Adams GP, Sumar J, Ginther OJ: Effects of lactational and reproductive
status on ovarian follicular waves in llamas (Lama glama). J Reprod Fertil
1990, 90:535-545.
11. Vaughan JL, Tibary A: Reproduction in female South American camelids:
A review and clinical observations. Small Rumin Res 2006, 61:259-281.
12. England BG, Foote WC, Cardozo AG, Matthews DH, Riera S: Oestrus and
mating behaviour in the llama (Lama glama). Anim Behav 1971,
19:722-726.
13. Reeves JJ: Endocrinology of Reproduction. Reproduction in farm animals
Philadelphia: Lea & FebigerHafez ESE , Fifth 1987, 85-106.
14. Bo GA, Adams GP, Pierson RA, Tribulo HE, Caccia M, Mapletoft RJ: Follicular
wave dynamics after estradiol-17b treatment of heifers with or without
a progestogen implant. Theriogenology 1994, 41:1555-1569.
15. Bo GA, Baruselli PS, Moreno D, Cutaia L, Caccia M, Tríbulo R, Tríbulo HE,
Mapletoft RJ: The control of follicular wave development for self-
appointed embryo transfer programs in cattle. Theriogenology 2002,
57:53-72, (review).
16. Burke CR, Mussard ML, Gasser CL, Grum DE, Day ML: Estradiol benzoate
delays new follicular wave emergence in a dose-dependent manner
after ablation of the dominant ovarian follicle in cattle. Theriogenology
2003, 60:647-658.
17. Martínez MF, Kastelic JP, Bo GA, Caccia M, Mapletoft RJ: Effects of
oestradiol and some of its esters on gonadotrophin release and ovarian
follicular dynamics in CIDR-treated beef cattle. Anim Reprod Sci 2005,
86:37-52.
18. Thundathil J, Kastelic JP, Mapletoft RJ: The effect of estradiol cypionate
(ECP) on ovarian follicular development and ovulation in dairy cattle.
Can J Vet Res 1997, 61:314-316.
19. Colazo MG, Kastelic JP, Mapletoft RJ: Effects of estradiol cypionate (ECP)
on ovarian follicular dynamics, synchrony of ovulation, and fertility in
CIDR-based, fixed-time AI programs in beef heifers. Theriogenology 2003,
60:855-865.
20. Bo GA, Bergfelt DR, Brogliatti GM, Pierson RA, Adams GP, Mapletoft RJ:
Local versus systemic effects of exogenous estradiol-17b on ovarian
follicular dynamics in heifers with progestogen implants. Anim Reprod Sci
2000, 59:141-157.
21. O’Rourke M, Diskin MG, Sreenan JM, Roche JF: The effect of dose and
route of oestradiol benzoate administration on plasma concentrations of
oestradiol and FSH in long-term ovariectomised heifers. Anim Reprod Sci
2000, 59:1-12.
22. Diskin MG, Austin EJ, Roche JF: Exogenous hormonal manipulation of
ovarian activity in cattle. Domest Anim Endocrinol 2002, 23:211-228,
(review).
23. D’Occhio MJ, Novoa C, Vera WG, Davalos : Ovarian follicle regression and
emergence of new follicular wave after injection of 17b-oestradiol in
alpacas. Australian Society for Reproductive Biology 1997, 29:102.
24. Vaughan JL: Control of ovarian follicular growth in the alpaca (Lama
pacos). PhD thesis Central Queensland University 2001.
25. Ratto MH, Singh J, Huanca W, Adams GP: Ovarian follicular wave
synchronization and pregnancy rate after fixed-time natural mating in
llamas. Theriogenology 2003, 60:1645-1656.
26. Skidmore JA, Adams GP, Billah M: Synchronisation of ovarian follicular
waves in the dromedary camel (Camelus dromedarius). Anim Reprod Sci
2009, 114:249-255.
27. Oukessou M: Kinetic disposition of flunixin meglumine in the camel
(Camelus dromedarius). Vet Res 1994, 25:71-75.
28. Ali BH, Oukessou M, Bashir AK: Pharmacokinetics considerations in the
camel (Camelus dromedarius). Comp Biochem Physiol 1996, 115:1-9.
29. Navarre CB, Ravis WR, Nagilla R, Deshmukh D, Simpkins A, Duran SH,
Pugh DG: Pharmacokinetics of flunixin meglumine in llamas following a
single intravenous dose. J Vet Pharmacol Ther 2001, 24:361-364.
30. Navarre CB, Ravis WR, Nagilla R, Simpkins A, Duran SH, Pugh DG:
Pharmacokinetics of phenylbutazone in llamas following single
intravenous and oral doses. J Vet Pharmacol Ther 2001, 24:227-231.
31. Cancino AK: Control exógeno de la dinámica folicular ovárica y respuesta
superovulatoria en llamas (Lama glama) con y sin cría al pie. (Exogenous
control of follicular dynamics and superovulatory response in lactating and
non lactating llamas (Lama glama). Master of Science thesis Facultad de Cs.
Agrarias, Universidad Nacional de Mar del Plata. Balcarce, Argentina 2005,
106.
32. Aba MA, Quiroga MA, Auza N, Forsberg M, Kindahl H: Control of ovarian
activity in llamas (Lama glama) with medroxyprogesterone acetate.
Reprod Domest Anim 1999, 34:471-476.
33. Sirois J, Fortune JE: Lengthening the bovine estrous cycle with low levels
of exogenous progesterone: a model for studying ovarian follicular
dominance. Endocrinology 1990, 127:916-925.
34. Bianchi CP, Meikle A, Sartore I, González F, Aba MA: Uterine estrogen
receptor alpha and progesterone receptor during the follicular and
luteal phase in llamas. Anim Reprod Sci 2007, 99:117-126.
35. Vynckier L, Debackere M, De Kruif A, Coryn M: Plasma estradiol-17b
concentrations in the cow during induced estrus and after injection of
estradiol-17b benzoate and estradiol-17b cypionate–a preliminary study.
J Vet Pharmacol Ther 1990, 13:36-42.
36. Baggot J: Pharmacokinetics: disposition and fate of drugs in the body.
Veterinary Pharmacology and Therapeutics Ames Iowa 50014, USA: Iowa
State University PressAdams R 1995, 18-52.
37. Aba MA: Hormonal interrelationships in reproduction of female llamas
and alpacas. PhD thesis Swedish University of Agricultural Sciences, Acta
Univ. Agricult. Sueciae Vet 1998, 35.
38. Chaves MG, Aba M, Agüero A, Egey J, Berestin V, Rutter B: Ovarian
follicular wave pattern and the effect of exogenous progesterone on
follicular activity in non-mated llamas. Anim Reprod Sci 2002, 69:37-46.
39. Aba MA: Studies on the reproductive endocrinology of llamas and
alpacas from mating throughout early pregnancy. Master of Science thesis
Swedish University of Agricultural Sciences, Uppsala 1995, 11-78.
40. Mapletoft RJ, Colazo MG, Martínez MF, Kastelic JP: Ésteres de estrógeno
para la sincronización de la emergencia de la onda folicular y la
ovulación en animales tratados con dispositivos con progesterona.
(Estradiol esters for synchronization of follicular wave emergence and
ovulation in animals treated with progesterone releasing intravaginal
devices). Proceedings of the V International Symposium of Animal
Reproduction, IRAC: 27-29 June Córdoba, Argentina 2003, 55-67.
doi:10.1186/1751-0147-52-13
Cite this article as: Cavilla et al.: Oestradiol-17b plasma concentrations
after intramuscular injection of oestradiol benzoate or oestradiol
cypionate in llamas (Lama glama). Acta Veterinaria Scandinavica 2010
52:13.
Cavilla et al. Acta Veterinaria Scandinavica 2010, 52:13
http://www.actavetscand.com/content/52/1/13
Page 5 of 5
